What does the Expanded Lung Cancer Panel include?
This panel at Metropolis Healthcare evaluates a wide range of genetic mutations linked to lung cancer to support targeted treatment decisions.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced molecular techniques, including high-sensitivity sequencing, to detect clinically relevant genetic changes.
Who should take this test?
Patients diagnosed with lung cancer or those being evaluated for targeted therapy may benefit from this panel at Metropolis Healthcare.
Why is molecular testing important in lung cancer?
Metropolis Healthcare performs this test to help identify actionable mutations that can guide personalized and more effective treatment options.
What sample is required for this test?
The Expanded Lung Cancer Panel at Metropolis Healthcare is typically performed on tumor tissue or other clinically appropriate specimens, as advised by the oncologist.
How long does it take to receive results?
Metropolis Healthcare generally provides results within a clinically appropriate turnaround time based on the complexity of genetic analysis.
Can this test help determine targeted therapy options?
Yes, results from Metropolis Healthcare’s panel often help doctors select targeted drugs that match the patient’s specific mutation profile.
Is this test useful for monitoring disease progression?
Yes, Metropolis Healthcare may recommend repeat testing in certain cases to track new mutations that could influence ongoing treatment.